Real-world Utilization and Adherence of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States: Updated Results From the PrEPFACTS Study Using Healthcare Administrative Claims Data

Conference Reports for NATAP

13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil


Real-world Utilization and Adherence of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States: Updated Results From the PrEPFACTS Study Using Healthcare Administrative Claims Data

	IAS 2026 Rio, Brazil